What Makes the Medicine the Biggest Recurring Cost in Medical Cannabis?

If you or someone you know has started prescribed cannabis treatment Click for source through the NHS or private prescriptions in the UK, you may have noticed that the ongoing medicine cost often outweighs every other expense. Medical cannabis is unique compared to many treatments—both in how it's delivered and how its cost structures operate. Let’s break down exactly what drives the biggest recurring cost in medical cannabis, focusing on dose-dependent spend, monthly repeat prescriptions, product price variability, and why the delivery device itself is regulated as part of your treatment.

UK Prescribed Cannabis Is Vaporised, Not Smoked

One of the most widespread misconceptions around prescribed cannabis in the UK is that patients "smoke" it. That's not accurate. Unlike recreational cannabis, medical cannabis prescribed by UK doctors is almost always vaporised rather than smoked.

Why vaporisation matters

Vaporisation heats the cannabis extract gently enough to release cannabinoids and terpenes as an aerosol (vapor) without burning the plant material. This means patients inhale active components without the harmful by-products of combustion.

Vaporisation: Releases cannabinoids at around 180–220°C without burning, which means fewer harmful compounds.
Smoking: Combusts plant material at over 600°C, creating tar, carbon monoxide, and numerous known carcinogens.

Simply put: Vaporised medical cannabis is kinder to lungs and more consistent dose-wise than smoking.

Combustion By-products vs Vaporisation: Impact on Health and Cost

Combustion (smoking) generates a complex mixture of toxic by-products including tar, ammonia, and carcinogens. These remain a significant characteristic of recreational cannabis use and contribute to respiratory issues.

Feature Vaporisation (Medical Cannabis) Combustion (Smoking) Temperature 180-220°C 600+°C By-products Minimal toxic by-products, mostly vapor Tar, carbon monoxide, carcinogens Health impact Reduced lung irritation, safer long-term use Higher risk of respiratory disease Dose consistency More accurate dosing possible Dosing varies wildly by how it's smoked

Because prescribed cannabis avoids combustion, it not only improves patient safety but also reduces variability in dose absorption. This consistency is vital as the medicine cost is dose-dependent—meaning the more consistent the dose, the more predictable and manageable your monthly prescription costs.

The Device as Part of the Treatment Plan

Unlike most medicines that come in pills or liquids, medical cannabis in the UK is supplied with a vaporiser device to deliver the dose. The device itself is regulated by both healthcare and pharmaceutical standards, often acting as a required companion to your prescription.

Why the vaporiser device matters

Ensures consistent dosing: Devices are precision-engineered to heat cannabis extracts exactly to the temperature specification, preventing overdose or underdose.
Patient safety: Medical vaporisers limit contamination or breakdown of cannabinoids.
Cost considerations: Devices are often one-off or infrequent purchases, but their performance directly influences how much medicine you use.

This integration means that when you get a repeat prescription, what you pay for isn’t just the medicine but an entire delivery system designed for safe, effective treatment.

Pharmacy and GPhC Regulation: What’s Allowed and What’s Not

Medical cannabis prescriptions must be dispensed by pharmacies following strict rules set by both the General Pharmaceutical Council (GPhC) and NHS regulations. These regulations help keep medicines safe, traceable, and of consistent quality.

Pharmacy role: Pharmacists check prescriptions, counsel patients on device use, and monitor for drug interactions.
GPhC standards: Enforce standards in storage, handling, and record-keeping for controlled medicines like cannabis.
Repeat prescription rules: Monthly continuous dispensing limits avoid misuse and ensure cost monitoring.

This regulatory environment means the recurring cost isn’t random; every monthly repeat you pay reflects careful management and safety controls that protect you as a patient.

Understanding Dose-Dependent Spend and Monthly Repeat Prescriptions

You know what's funny? medical cannabis prescribing is not a fixed-price situation because your dose directly affects cost. The more milligrams or milliliters you require per day, the higher your monthly medicine cost.

Here’s why dose-dependent spend matters:

Individual variability: One patient might need a few milligrams a day, another much higher doses depending on the condition.
Daily usage adds up: Small daily differences multiply over 30-day repeat prescriptions.
Product concentration: Different cannabis products have varying cannabinoid concentrations, impacting the volume needed.

For example, a low concentration oil taken twice a day could cost less monthly than a highly concentrated extract taken three times a day, even if the latter is more effective per dose.

Product Price Variability Across Prescribed Cannabis

There is notable price variability across medical cannabis products licensed or unlicensed for prescription use in the UK:

Extract types: Oils, capsules, or dried flower extracts have different manufacturing complexities.
THC to CBD ratio: Products with higher THC content generally cost more due to production requirements.
Brand and supplier: Prices fluctuate by manufacturer and pharmacy dispensing agreements.

Breaking down medical cannabis vaporiser devices pricing per milliliter or per milligram can help patients and clinicians understand true monthly costs rather than vague estimates.

Product Type Approximate Cost per mL (£) Typical Monthly Usage (mL) Estimated Monthly Cost (£) CBD-dominant oil (5%) £50 5 £250 Balanced THC:CBD oil (10%) £70 5 £350 High-THC extract (20%) £120 3 £360

Prices can vary, but these estimates illustrate that monthly medicine spend ranges from a few hundred to multiple hundreds of pounds, making it the dominant recurring cost.

Summary: Why Medicine Is the Big Recurring Cost in Medical Cannabis

To recap the key points:

Prescribed cannabis in the UK is vaporised, not smoked, reducing harm and enabling dose consistency.
Vaporisation avoids combustion by-products, prioritising patient safety and better dose control.
The vaporiser device is an essential, regulated part of treatment, ensuring safe delivery and affecting overall cost indirectly.
Pharmacy and GPhC regulations keep cannabis medicines and devices strictly controlled, ensuring quality but influencing dispensing costs.
Patient spend depends heavily on dose, product type, and prescription frequency, making monthly repeat prescriptions the primary ongoing expense.
Product price variability means understanding cost-per-dose is crucial for managing long-term affordability.

Medical cannabis is a complex treatment with an entirely different cost structure than many standard drugs. The biggest cost recurring monthly is not the device or initial consultation fees, but the medicine itself—because the dosing and product type directly scale the cost.

For patients navigating this new landscape, understanding these factors can help better plan treatment budgets and enable informed discussions with prescribers and pharmacists.